The total return over the past 12 months is +38.22% vs. +16.94% for the S&P 500. So far it's up +250.66% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +38.22% | +66.37% | +43.90% | +33.70% | +27.94% | +28.34% |
| Total Return CAGR | +38.22% | +66.37% | +43.90% | +33.70% | +27.94% | +28.34% |
| Revenue CAGR | +16.02% | +24.72% | +19.35% | +29.22% | N/A | +50.92% |
| Net Income CAGR | (58.66%) | (16.59%) | (10.87%) | +45.23% | N/A | N/A |
| EPS CAGR | (58.73%) | 0.00% | +0.64% | N/A | N/A | N/A |
| Free Cash Flow CAGR | (40.69%) | (7.43%) | (4.40%) | +26.89% | N/A | N/A |
| Operating Cash Flow CAGR | (39.79%) | (6.75%) | (4.11%) | +27.15% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Corcept Therapeutics Incorporated (CORT)
| Year | Start price | End price | CORT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $34.80 | $122.03 | +250.66% | +14.51% | +236.15% |
| 2025 | $50.39 | $34.80 | (30.94%) | +17.72% | (48.66%) |
| 2024 | $32.48 | $50.39 | +55.14% | +24.89% | +30.25% |
| 2023 | $20.31 | $32.48 | +59.92% | +26.19% | +33.73% |
| 2022 | $19.80 | $20.31 | +2.58% | (18.17%) | +20.75% |
| 2021 | $26.16 | $19.80 | (24.31%) | +28.74% | (53.05%) |
| 2020 | $12.10 | $26.16 | +116.20% | +18.37% | +97.83% |
| 2019 | $13.36 | $12.10 | (9.43%) | +31.22% | (40.65%) |
| 2018 | $18.06 | $13.36 | (26.02%) | (4.56%) | (21.46%) |
| 2017 | $7.26 | $18.06 | +148.76% | +21.70% | +127.06% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
